Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 469

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 469
---
167 shares of common stock issuable upon the exercise of options within 60 days of 
 December 31, 2024.                                                                                |

| (16) | Consists of 63,314 shares of common stock issuable upon the exercise of options within 60 days of 
 December 31, 2024.                                                                                |

| (17) | Consists of 3,399 shares of common stock issuable upon the exercise of options within 60 days of 
 December 31, 2024.                                                                               |

| (18) | Consists of an aggregate of (i) 7,786,908 shares of common stock; (ii) 2,129,868 shares issuable upon the                                                                                                                                 
 exercise of stock options within 60 days of December 31, 2024; and (iii); 35,500 shares issuable upon the vesting of restricted stock units within 60 days of December 31, 2024 held by our current executive officers and directors as a 
 group.                                                                                                                                                                                                                                    |

- 316 -

PRINCIPAL STOCKHOLDERS OF AADI AFTER THE PIPE FINANCING The following table sets forth information relating to the expected beneficial ownership of our common stock immediately after closing of the PIPE Financing, assuming the closing occurred on December 31, 2024, by:

| • |     | each person, or group of affiliated persons, expected to beneficially own more than 5% of the outstanding shares 
 of our common stock, assuming closing of the PIPE Financing;                                                     |

| • |     | each of our directors; |

| • |     | each of our named executive officers; and |

| • |     | all current directors and executive officers as a group. |

The number of shares beneficially owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days of December 31, 2024 through the exercise of any stock option, warrants or other rights. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock held by such persons. - 317 -

The percentage of shares beneficially owned is computed on the